Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations

Journal of Thoracic and Cardiovascular Surgery

Volumn 121, Issue 2, 2001, Pages 324-330

  Øvrum, Eivind ^a   Tangen, Geir ^a   Øystese, Rolf ^a   Ringdal, Mari Anne L ^a   Istad, Reidar ^a  

^a Oslo Heart Center   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURFACE PROPERTY; TREATMENT OUTCOME;

EID: 0035130414     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2001.111205     Document Type: Article

References (25)

1. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations
2. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass
3. Reduced complement and granulocyte activation with heparin coated cardiopulmonary bypass
4. Complement activation during cardiopulmonary bypass: Effect of immobilized heparin
5. Complement and the damaging effects of cardiopulmonary bypass
6. Heparin-coated bypass circuits reduce pulmonary injury
7. Risk and benefit of low systemic heparinization during open heart operations
8. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: A prospective, randomized study
9. Completely heparinized cardiopulmonary bypass and reduced systemic heparin; clinical and hemostatic effects
10. Clinical effects of the heparin coated surface in cardiopulmonary bypass
11. Coating-techniques to improve the hemo-compatibility of artificial devices used for extracorporeal circulation
12. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue
13. Principles of heparin-coating techniques
14. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits
15. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems
16. Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass
17. Consistent non-pharmacologic blood conservation in primary and reoperative coronary artery bypass grafting
18. Assessment of heparin anticoagulation: Comparison of two commercially available methods
19. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits
20. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass
21. Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass
22. Cardiovascular effects of protamine sulfate in man
23. Clinical evaluation of Duraflo II heparin treated extracorporeal circulation circuits (2nd version). The European working group on heparin coated extracorporeal circulation circuits
24. Heparin-coated circuits for high-risk patients: A multicenter, prospective, randomized trial
25. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance